Most Read Articles
Stephen Padilla, 04 Sep 2019
Use of sodium glucose cotransporter 2 (SGLT2), as compared with dipeptidyl peptidase 4 (DPP4), inhibitors appears to reduce the risk of heart failure and any-cause death without major cardiovascular events in the primary intention-to-treat analysis, according to a study.
Pearl Toh, 04 Sep 2019
More intensive LDL-lowering by adding ezetimibe to simvastatin in elderly individuals aged ≥75 years significantly reduced recurrent cardiovascular (CV) events without raising safety issues compared with simvastatin alone, a secondary analysis of the IMPROVE-IT* has shown.
27 Aug 2019
A once-weekly regimen of 25 mg trelagliptin is effective and safe for type 2 diabetes mellitus (T2DM) patients with severe renal impairment or end-stage renal disease, reports a new study.
Elvira Manzano, 4 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pharmacists’ town hall with Ministry of Health: Preliminary highlights

Rachel Soon
Medical Writer
16 Aug 2019
Pharmacists in attendance at a town hall organized by the Ministry of Health, Malaysia.

On 8 August, the first town hall held by the Ministry of Health (MOH) with members of the pharmacy profession took place in Putrajaya. Over 500 pharmacists from across the country and from different areas of practice—community and hospital, public and private, academy and industry—converged to fill the auditorium for the chance to engage in direct dialogue with MOH.

The panellists consisted of Datuk Seri Dr Dzulkefly Ahmad, Minister of Health; Datuk Dr Noor Hisham Abdullah, Director-General of Health, MOH; Dato’ Seri Dr Chen Chaw Min, Secretary-General, MOH; and Dr Ramli Zainal, Senior Director of the Pharmaceutical Services Division (PSD), MOH.

In an opening speech, Dzulkefly acknowledged that a wide range of suggestions and recommendations on policy, regulation, human resource, and capacity-building, received by the MOH from pharmacists had led to the focused discourse of the town hall.

“As experts in drugs and matters related to drugs, you represent an important group of healthcare professionals in the country; you are well positioned to contribute much to the health and well-being of the nation,” said Dzulkefly. “We would like to assure you that your voice and opinions in further advancing our healthcare services will be looked into seriously by the MOH.”

Clockwise from top left: pharmacist association representatives Amrahi Buang, MPS president; Susan Tang, Sarawak Pharmaceutical Society president;  Lovy Beh, MCPG president; and Jemima Ho, Sabah Pharmaceutical Society president, presenting points at the MOH-pharmacists town hall.

Clockwise from top left: pharmacist association representatives Amrahi Buang, MPS president; Susan Tang, Sarawak Pharmaceutical Society president; Lovy Beh, MCPG president; and Jemima Ho, Sabah Pharmaceutical Society president, presenting points at the MOH-pharmacists town hall.

Presenting key issues to the panel were Amrahi Buang, Malaysian Pharmaceutical Society (MPS) president; Jemima Ho, Sabah Pharmaceutical Society president; Susan Tang, Sarawak Pharmaceutical Society president; Rahman Baco, Bumiputera Pharmacists’ Society (BUMIFARMA) president; and Lovy Beh, Malaysian Community Pharmacy Guild (MCPG) president. A limited number of audience members were also invited to question the panellists.

The town hall was livestreamed via Facebook Live on both the MPS and the MOH’s Facebook pages. The recorded video with the panellists’ responses remains available for public viewing currently.

Pharmacist-MOH town hall key points

Dispensing separation, other reforms await national health financing scheme

Major reforms such as dispensing separation and public-private transition of care (TOC) can only be fulfilled with the support of a single national health financing scheme, said the Health Minister.

“The thrust of reform essentially will be driven by a national health financing system. We can no longer go on with a predominantly tax-based system. That served us well, but it is no longer sustainable,” said Dzulkefly. “A national health trust fund would enable coverage of both the public and private sector. In that scenario, I believe you would have [policies such as] dispensing separation in place … as well as other things like strategic purchasing, pooled procurement and public-private care collaborations.”

He added that a national health financing system would have to be implemented together with a restructuring and corporatization of the MOH to improve efficiency in the longer term.

Moratorium on new pharmacy courses under consideration

L-R: Datuk Dr Noor Hisham Abdullah, Director-General of Health, MOH; Datuk Seri Dr Dzulkefly Ahmad, Minister of Health; Dato’ Seri Dr Chen Chaw Min, Secretary-General, MOH; and Dr Ramli Zainal, Senior Director of the Pharmaceutical Services Division (PSD), MOH, speaking at the MOH-pharmacists town hall.

L-R: Datuk Dr Noor Hisham Abdullah, Director-General of Health, MOH; Datuk Seri Dr Dzulkefly Ahmad, Minister of Health; Dato’ Seri Dr Chen Chaw Min, Secretary-General, MOH; and Dr Ramli Zainal, Senior Director of the Pharmaceutical Services Division (PSD), MOH, speaking at the MOH-pharmacists town hall.

Addressing the request for a moratorium on new pharmacy programmes, Ramli said that a new proposal had been submitted in April 2019 and is currently under review by the Pharmacy Board with the aid of the deans of relevant universities.

Ramli noted that similar proposals had been submitted in 2011 and 2016, but turned down by the Ministry of Higher Education, on the grounds that data projections still showed a need for more pharmacists to cater to national population numbers.

“The issue is more [about the fact] that government posts are almost filled up … so there is a sense of an overwhelming number of pharmacy graduates in the market,” said Ramli.

At present, 1,200 to 1,300 graduates are being produced per year, but in 2019 a major decline in pharmacy programme enrolments was observed among private universities. Ramli estimated that there would be under 1,000 graduates a year by 2023 as a result. He added that in 2018, a total of 14,479 pharmacists renewed their annual practicing certificates.

No new legal provisions on mandatory prescribing

An audience member questions the MOH panelists at the town hall.

An audience member questions the MOH panelists at the town hall.

While a calm atmosphere held through most of the town hall’s questions and answers, the mood turned briefly heated when the Health Minister informed that at present, the issuance of prescriptions by doctors remained mandatory only on patient request.

“We believe that everything has its time, and we will consider [mandatory prescription] seriously, but for now, [it is] mandatory upon request. But as and when we feel we are able to do it, we will at the soonest,” said Dzulkefly.

The questioner, MCPG council member Sarah Abdullah, expressed dissatisfaction with the answer and pressed Dzulkefly and Noor Hisham to explain why the status quo was being maintained despite inherent issues of patient rights and safety. However, when Noor Hisham only reiterated that such was the MOH’s stance, objections and demands for explanation could be heard from the audience.

A subsequent questioner raised the issue again, pointing out that patient awareness of their prescription rights was poor across the country. In addition, she highlighted a recent MPS survey of 100 patients which found that 69 of them had experienced general practitioners rejecting their requests for a prescription.

“If the patient visits the doctor and requests for a prescription, it is mandatory for the doctor to give one to the patient,” replied Noor Hisham.

Both he and Dzulkefly said that to improve patient education on the matter, the MOH could undertake a social media campaign on all its available channels. Dzulkefly added that a special complaints line for patients encountering issues with obtaining prescriptions could be established.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 04 Sep 2019
Use of sodium glucose cotransporter 2 (SGLT2), as compared with dipeptidyl peptidase 4 (DPP4), inhibitors appears to reduce the risk of heart failure and any-cause death without major cardiovascular events in the primary intention-to-treat analysis, according to a study.
Pearl Toh, 04 Sep 2019
More intensive LDL-lowering by adding ezetimibe to simvastatin in elderly individuals aged ≥75 years significantly reduced recurrent cardiovascular (CV) events without raising safety issues compared with simvastatin alone, a secondary analysis of the IMPROVE-IT* has shown.
27 Aug 2019
A once-weekly regimen of 25 mg trelagliptin is effective and safe for type 2 diabetes mellitus (T2DM) patients with severe renal impairment or end-stage renal disease, reports a new study.
Elvira Manzano, 4 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.